Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cholelithiasis × Observation × Gastrointestinal × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 14 Stomach Neoplasms 12 Pancreatic Neoplasms 9 Colonic Neoplasms 7 Carcinoma, Hepatocellular 7 Esophageal Neoplasms 6 Rectal Neoplasms 5 Colorectal Neoplasms, Hereditary Nonpolyposis 4 Anus Neoplasms 4 Neoplasms 3 Gastrointestinal Stromal Tumors 3 Gastrointestinal Neoplasms 3 Gallbladder Neoplasms 3 Vulvar Neoplasms 2 Uterine Cervical Neoplasms 2 Squamous Intraepithelial Lesions 2 Peritoneal Neoplasms 2 Ovarian Neoplasms 2 Endometrial Neoplasms 2 Cholangiocarcinoma 2 Bile Duct Neoplasms 2 Acquired Immunodeficiency Syndrome 2 Vaginal Neoplasms 1 Urinary Bladder Neoplasms 1 Skin Neoplasms 1 Recurrence 1 Pseudomyxoma Peritonei 1 Prostatic Neoplasms 1 Papillomavirus Infections 1 Pancreatic Tubular Adenocarcinoma 1

Interventions

Surveys and Questionnaires 1 Phlebotomy 1 Observation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06192719 2026-02-18

EULAT

Centre Paul Strauss

15,000 enrolled

Gastrointestinal

Cholelithiasis, Gallbladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡